GENERAL CONSIDERATIONS
Biologic Behaviour
•oral OSA is the 4th most common oral tumor in dogs and accounts for 6%-18% of oral tumors
•OSA is more common in appendicular skeleton with only 25.4% in the axial skeleton
•mandibular OSA accounts for 27% of axial OSA (and < 4% of all OSA cases)
•axial OSA, and mandibular OSA in particular, may have a lower metastatic rate than appendicular OSA
TREATMENT
Surgery
•surgical techniques: mandibulectomy and maxillectomy
Surgery and Radiopharmaceuticals
•samarium has been used following partial maxillectomy and local recurrence with survival times > 21 months
Prognosis
•12-month survival rate 59%
•12-month survival rate with combinations of surgery, radiation therapy, and chemotherapy: 35%-59%
•MST for mandibulectomy is 14-18 months with 12-month survival rate 35%-71%, local recurrence rate 15%-28%, and metastatic rate 28%
•MST for maxillectomy is 4.6-10 months with 12-month survival rate 17%-27% and recurrence rate 33%
•poor prognostic factor: high histologic grade for mandibular OSA treated with mandibulectomy
SURGICAL ONCOLOGY
SOCIETY
RESEARCH
EDUCATION
LINKS
EMPLOYMENT
ORAL OSTEOSARCOMA